| Dr Sumia Rashid, MD | |
|
427 W 20th St Ste 300, Houston, TX 77008-2429 | |
| (713) 791-1633 | |
| (713) 791-1710 |
| Full Name | Dr Sumia Rashid |
|---|---|
| Gender | Female |
| Speciality | Nephrology |
| Experience | 25 Years |
| Location | 427 W 20th St Ste 300, Houston, Texas |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1073784252 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RN0300X | Internal Medicine - Nephrology | 2008005523 (Missouri) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Med Center Dialysis | Houston, TX | Dialysis facility |
| Tc Jester Dialysis | Houston, TX | Dialysis facility |
| Memorial Hermann - Texas Medical Center | Houston, TX | Hospital |
| Park Plaza Hospital | Houston, TX | Hospital |
| Houston Methodist Hospital | Houston, TX | Hospital |
| St Joseph Medical Center | Houston, TX | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Pedro J Frommer Md Pa | 6002865813 | 3 |
| Kidney And Hypertension Consultants Of Houston Pa | 9739204744 | 6 |
News Archive
Children without previous iron deficiencies or anemia who remained infected with Helicobacter pylori had significantly lower levels of iron compared to children who had the infection eradicated, according to researchers at The University of Texas Health Science Center at Houston.
RTI International has been awarded a contract from the Robert Wood Johnson Foundation to develop an online database and communication platform to help public health professionals share information about quality improvement initiatives.
A modified mastectomy technique provides effective treatment for breast cancer while preserving the nipple and surrounding tissues for use in breast reconstruction, according to a report in the November issue of Plastic and Reconstructive Surgery, the official medical journal of the American Society of Plastic Surgeons.
Orabrush, the tongue cleaner that helps cure bad breath, today announced that the company has closed a $2.5 million investment round with True Ventures of Palo Alto and returning investor 2x Consumer Products Growth Partners of Chicago. Funds will be used to help further accelerate the company's retail growth by maximizing its exceptional online brand and expanding its retail partnerships and distribution channels throughout the world.
OSI Pharmaceuticals, Inc. announced today that the U.S. Patent & Trademark Office has issued a "Notice of Allowance" in OSI's reissue application for U.S. Patent No.5,747,498 (the ‘498) composition of matter patent for Tarceva® (erlotinib). The reissued patent will replace the original ‘498 patent and have the same November 2018 expiration date.
› Verified 5 days ago
| Entity Name | Pedro J Frommer Md Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1326067554 PECOS PAC ID: 6002865813 Enrollment ID: O20050119000760 |
News Archive
Children without previous iron deficiencies or anemia who remained infected with Helicobacter pylori had significantly lower levels of iron compared to children who had the infection eradicated, according to researchers at The University of Texas Health Science Center at Houston.
RTI International has been awarded a contract from the Robert Wood Johnson Foundation to develop an online database and communication platform to help public health professionals share information about quality improvement initiatives.
A modified mastectomy technique provides effective treatment for breast cancer while preserving the nipple and surrounding tissues for use in breast reconstruction, according to a report in the November issue of Plastic and Reconstructive Surgery, the official medical journal of the American Society of Plastic Surgeons.
Orabrush, the tongue cleaner that helps cure bad breath, today announced that the company has closed a $2.5 million investment round with True Ventures of Palo Alto and returning investor 2x Consumer Products Growth Partners of Chicago. Funds will be used to help further accelerate the company's retail growth by maximizing its exceptional online brand and expanding its retail partnerships and distribution channels throughout the world.
OSI Pharmaceuticals, Inc. announced today that the U.S. Patent & Trademark Office has issued a "Notice of Allowance" in OSI's reissue application for U.S. Patent No.5,747,498 (the ‘498) composition of matter patent for Tarceva® (erlotinib). The reissued patent will replace the original ‘498 patent and have the same November 2018 expiration date.
› Verified 5 days ago
| Entity Name | Southeast Texas Nephrology Associates, Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1376543074 PECOS PAC ID: 0749207090 Enrollment ID: O20051026001091 |
News Archive
Children without previous iron deficiencies or anemia who remained infected with Helicobacter pylori had significantly lower levels of iron compared to children who had the infection eradicated, according to researchers at The University of Texas Health Science Center at Houston.
RTI International has been awarded a contract from the Robert Wood Johnson Foundation to develop an online database and communication platform to help public health professionals share information about quality improvement initiatives.
A modified mastectomy technique provides effective treatment for breast cancer while preserving the nipple and surrounding tissues for use in breast reconstruction, according to a report in the November issue of Plastic and Reconstructive Surgery, the official medical journal of the American Society of Plastic Surgeons.
Orabrush, the tongue cleaner that helps cure bad breath, today announced that the company has closed a $2.5 million investment round with True Ventures of Palo Alto and returning investor 2x Consumer Products Growth Partners of Chicago. Funds will be used to help further accelerate the company's retail growth by maximizing its exceptional online brand and expanding its retail partnerships and distribution channels throughout the world.
OSI Pharmaceuticals, Inc. announced today that the U.S. Patent & Trademark Office has issued a "Notice of Allowance" in OSI's reissue application for U.S. Patent No.5,747,498 (the ‘498) composition of matter patent for Tarceva® (erlotinib). The reissued patent will replace the original ‘498 patent and have the same November 2018 expiration date.
› Verified 5 days ago
| Entity Name | Kidney And Hypertension Consultants Of Houston Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1871818997 PECOS PAC ID: 9739204744 Enrollment ID: O20100914001331 |
News Archive
Children without previous iron deficiencies or anemia who remained infected with Helicobacter pylori had significantly lower levels of iron compared to children who had the infection eradicated, according to researchers at The University of Texas Health Science Center at Houston.
RTI International has been awarded a contract from the Robert Wood Johnson Foundation to develop an online database and communication platform to help public health professionals share information about quality improvement initiatives.
A modified mastectomy technique provides effective treatment for breast cancer while preserving the nipple and surrounding tissues for use in breast reconstruction, according to a report in the November issue of Plastic and Reconstructive Surgery, the official medical journal of the American Society of Plastic Surgeons.
Orabrush, the tongue cleaner that helps cure bad breath, today announced that the company has closed a $2.5 million investment round with True Ventures of Palo Alto and returning investor 2x Consumer Products Growth Partners of Chicago. Funds will be used to help further accelerate the company's retail growth by maximizing its exceptional online brand and expanding its retail partnerships and distribution channels throughout the world.
OSI Pharmaceuticals, Inc. announced today that the U.S. Patent & Trademark Office has issued a "Notice of Allowance" in OSI's reissue application for U.S. Patent No.5,747,498 (the ‘498) composition of matter patent for Tarceva® (erlotinib). The reissued patent will replace the original ‘498 patent and have the same November 2018 expiration date.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Sumia Rashid, MD 427 W 20th St Ste 300, Houston, TX 77008-2429 Ph: (713) 791-1633 | Dr Sumia Rashid, MD 427 W 20th St Ste 300, Houston, TX 77008-2429 Ph: (713) 791-1633 |
News Archive
Children without previous iron deficiencies or anemia who remained infected with Helicobacter pylori had significantly lower levels of iron compared to children who had the infection eradicated, according to researchers at The University of Texas Health Science Center at Houston.
RTI International has been awarded a contract from the Robert Wood Johnson Foundation to develop an online database and communication platform to help public health professionals share information about quality improvement initiatives.
A modified mastectomy technique provides effective treatment for breast cancer while preserving the nipple and surrounding tissues for use in breast reconstruction, according to a report in the November issue of Plastic and Reconstructive Surgery, the official medical journal of the American Society of Plastic Surgeons.
Orabrush, the tongue cleaner that helps cure bad breath, today announced that the company has closed a $2.5 million investment round with True Ventures of Palo Alto and returning investor 2x Consumer Products Growth Partners of Chicago. Funds will be used to help further accelerate the company's retail growth by maximizing its exceptional online brand and expanding its retail partnerships and distribution channels throughout the world.
OSI Pharmaceuticals, Inc. announced today that the U.S. Patent & Trademark Office has issued a "Notice of Allowance" in OSI's reissue application for U.S. Patent No.5,747,498 (the ‘498) composition of matter patent for Tarceva® (erlotinib). The reissued patent will replace the original ‘498 patent and have the same November 2018 expiration date.
› Verified 5 days ago
Dr. Michaela Elizabeth Ginn, MD Nephrology Medicare: Not Enrolled in Medicare Practice Location: 13214 Indian Creek Road, Houston, TX 77079 Phone: 713-591-3555 Fax: 661-321-3286 | |
Ameena Bagree Malhotra, M.D. Nephrology Medicare: Accepting Medicare Assignments Practice Location: 1515 Holcombe Blvd, 77030-4009, Houston, TX 77030 Phone: 713-792-6161 | |
Svetang Vijay Desai, M.D. Nephrology Medicare: Accepting Medicare Assignments Practice Location: 444 Fm 1959 Rd, Suite A, Houston, TX 77034 Phone: 281-481-9400 | |
Dr. Stalin R Subramanian, M.D Nephrology Medicare: Medicare Enrolled Practice Location: 7200 Cambridge St Fl 8, Houston, TX 77030 Phone: 713-798-0950 | |
Robin Boliver-campbell, M.D. Nephrology Medicare: Medicare Enrolled Practice Location: 7141 Southwest Fwy, Houston, TX 77074 Phone: 713-771-7921 Fax: 713-264-8659 | |
Henna Mukhtar Malik, M.D. Nephrology Medicare: Accepting Medicare Assignments Practice Location: 13215 Dotson Rd Ste 300, Houston, TX 77070 Phone: 281-894-8822 | |
Zaven Sargsyan, MD Nephrology Medicare: Accepting Medicare Assignments Practice Location: 1504 Taub Loop, Houston, TX 77030 Phone: 713-873-8890 |